StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Seres Therapeutics (MCRB) PT Lowered to $17 at Oppenheimer
August 3, 2018 9:25 AM
Oppenheimer lowered its price ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
BofA/Merrill Lynch Downgrades Seres Therapeutics (MCRB) to Underperform
August 3, 2018 6:10 AM
Form 10-Q Seres Therapeutics, Inc. For: Jun 30
August 2, 2018 11:38 AM
Seres Therapeutics (MCRB) Misses Q2 EPS by 5c, Revenues Miss
August 2, 2018 7:20 AM
Form 8-K Seres Therapeutics, Inc. For: Aug 02
August 2, 2018 7:09 AM
Seres Therapeutics Reports Second Quarter Financial Results and Provides Operational Updates
August 2, 2018 7:00 AM